Literature DB >> 29526559

Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.

Tian-Tian Li1, Xiang Gao1, Li Gao1, Bin-Liang Gan1, Zu-Cheng Xie1, Jing-Jing Zeng2, Gang Chen1.   

Abstract

BACKGROUND: It is generally acknowledged that miRNAs play pivotal roles in the initiation and development of cancer. The aim of the current study is to investigate the clinicopathological role of miR-136-5p in lung adenocarcinoma and its underlying molecular mechanism.
MATERIALS AND METHODS: Data of a cohort of 1242 samples were provided by the Gene Expression Omnibus and The Cancer Genome Atlas to evaluate miR-136-5p expression in lung adenocarcinoma. A comprehensive meta-analysis integrating the expression data from all sources was performed, followed by a summary receiver operating curve plotted to appraise the upregulated expression of miR-136-5p in lung adenocarcinoma. Candidate targets of miR-136-5p were launched by the intersection of differentially expressed genes in The Cancer Genome Atlas and genes predicted by 12 web-based platforms. Then, hub genes were illustrated by a protein-protein interaction network. Furthermore, Kyoto Encyclopedia of Genes and Genomes, Gene Ontology and Protein Analysis Through Evolutionary Relationships analyses of potential target genes were carried out via bioinformatics tools.
RESULTS: MiR-136-5p expression was upregulated in lung adenocarcinoma versus normal tissues (standard mean difference = 0.43, 95% confidence interval: 0.27-0.58). The summary receiver operating characteristic curve further verified the upregulation of miR-136-5p in lung adenocarcinoma (area under curve = 0.7459). A total of 311 candidate target genes of miR-136-5p were gathered to create a protein-protein interaction network. Molecular mechanism analysis unveiled the potential miR-136-5p target genes participated in cell adhesion molecules, focal adhesion, complement and coagulation cascades and blood coagulation.
CONCLUSION: MiR-136-5p is overexpressed in lung adenocarcinoma and is involved in the molecular mechanism of lung adenocarcinoma via suppressing the expressions of downstream targets, especially claudin-18, sialophorin and syndecan 2 that participate in cell adhesion.
Copyright © 2018. Published by Elsevier GmbH.

Entities:  

Keywords:  Bioinformatics; Cell adhesion molecules; Lung adenocarcinoma; Meta-analysis; miR-136a-5p

Mesh:

Substances:

Year:  2018        PMID: 29526559     DOI: 10.1016/j.prp.2018.02.017

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

Review 1.  The Role of ERα36 in Development and Tumor Malignancy.

Authors:  Charlène Thiebaut; Henri-Philippe Konan; Marie-Justine Guerquin; Amand Chesnel; Gabriel Livera; Muriel Le Romancer; Hélène Dumond
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

2.  Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma.

Authors:  Yuzhu Wang; Xu Zhao; Jing Li; Xuan Wang; WeiBin Hu; Xiaozhi Zhang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

3.  Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma.

Authors:  Zhizhi Zhuang; Liping Chen; Yuting Mao; Qun Zheng; Huiying Li; Yueyue Huang; Zijing Hu; Yi Jin
Journal:  Int J Biol Sci       Date:  2020-03-25       Impact factor: 6.580

4.  Prognostic value and prospective molecular mechanism of miR-100-5p in hepatocellular carcinoma: A comprehensive study based on 1,258 samples.

Authors:  Qing-Lin He; Shan-Yu Qin; Lin Tao; Hong-Jian Ning; Hai-Xing Jiang
Journal:  Oncol Lett       Date:  2019-10-04       Impact factor: 2.967

5.  Circular RNA VRK1 correlates with favourable prognosis, inhibits cell proliferation but promotes apoptosis in breast cancer.

Authors:  Yang Li; Hai Li
Journal:  J Clin Lab Anal       Date:  2020-01       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.